| Literature DB >> 20674812 |
Sebastian Grimm1, Emma Lundberg, Feifan Yu, Seiji Shibasaki, Erik Vernet, Marie Skogs, Per-Åke Nygren, Torbjörn Gräslund.
Abstract
Development of molecules with the ability to selectively inhibit particular protein-protein interactions is important in providing tools for understanding cell biology. In this work, we describe efforts to select small Ras- and Raf-specific three-helix bundle affibody binding proteins capable of inhibiting the interaction between H-Ras and Raf-1, from a combinatorial library displayed on bacteriophage. Target-specific variants with typically high nanomolar or low micromolar affinities (K(D)) could be selected successfully against both proteins, as shown by dot blot, ELISA and real-time biospecific interaction analyses. Affibody molecule variants selected against H-Ras were shown to bind epitopes overlapping each other at a site that differed from that at which H-Ras interacts with Raf-1. In contrast, an affibody molecule isolated during selection against Raf-1 was shown to effectively inhibit the interaction between H-Ras and Raf-1 in a dose-dependent manner. Possible intracellular applications of the selected affibody molecules are discussed.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20674812 DOI: 10.1016/j.nbt.2010.07.016
Source DB: PubMed Journal: N Biotechnol ISSN: 1871-6784 Impact factor: 5.079